{
  "paper_metadata": {
    "pmid": "39768907",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Glu54Gln, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.162G>A",
      "protein_notation": "p.Glu54Gln",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 14,
        "demographics": "Mean age 44.6 years, mixed gender",
        "phenotype": "hATTR with mixed axonal polyneuropathy and cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 11,
        "unaffected_count": 3,
        "uncertain_count": null,
        "penetrance_percentage": 78.57,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 100.0,
            "carriers_in_range": 5,
            "affected_in_range": 5
          },
          {
            "age_range": "41-50 years",
            "penetrance_percentage": 66.67,
            "carriers_in_range": 6,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "mixed axonal polyneuropathy, cardiomyopathy",
          "evidence_sentence": "The entire hATTR group displayed mixed, axonal polyneuropathy and cardiomyopathy; 85.7% of them had CTS."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 43,
          "age_at_onset": 38,
          "age_at_diagnosis": 40,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "mixed axonal polyneuropathy",
          "evidence_sentence": "The patients displayed additional reduced muscle strength, some reaching stage 3A and 3B-PND at the end of the study."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 46,
          "age_at_onset": 41,
          "age_at_diagnosis": 43,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms at evaluation",
          "evidence_sentence": "The remaining patients exhibited the following changes: five patients (38.46%) progressed to stage 2."
        }
      ],
      "functional_data": {
        "summary": "The Glu54Gln variant is associated with significant impairment of nerve parameters.",
        "assays": [
          "Electromyography (EMG)",
          "Nerve conduction studies"
        ]
      },
      "segregation_data": "Segregates with disease in families, especially in endemic regions.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Moderate evidence based on clinical presentation and family segregation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Glu54Gln mutation is the most common hATTR mutation encountered in Romania.",
      "key_quotes": [
        "The Glu54Gln mutation is the most common hATTR mutation encountered in Romania.",
        "The entire hATTR group displayed mixed, axonal polyneuropathy and cardiomyopathy."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text, focusing on the TTR gene."
  }
}